Anxiety Disorders
📧 Sign up to get email alerts when something new happens for Anxiety Disorders.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-12-15Clinical Trial Update: VR Mindfulness Study [NA]
A UCLA-sponsored VR mindfulness clinical trial focusing on anxiety and depression has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-09-25Clinical Trial Update: Investigating the Protective Impact of LY-2940094 on Stress-induced Depression- and Anxiety-related Phenotypes in Humans [Phase 2]
Phase 2 trial evaluating LY-2940094 for protection against stress-induced depression and anxiety phenotypes has been withdrawn before comple…
-
CLINICAL_TRIALS withdrawal · 2025-08-19Clinical Trial Update: Effect of App-driven Deep Breathing (NEURODIGITX) on Anxiety Levels and Quality of Life in Caregivers [NA]
A clinical trial evaluating the NEURODIGITX app-delivered deep breathing for anxiety and quality of life in caregivers has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-08-03Clinical Trial Update: Mindfulness in Medical Training [NA]
A clinical trial on mindfulness in medical training focusing on burnout, anxiety, and sleep has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-06-11Clinical Trial Update: Evaluating an Online Wellness Intervention for Greek Adolescents [NA]
The clinical trial evaluating an online wellness intervention for Greek adolescents has been withdrawn. The study targeted depressive sympto…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Anxiety
A non-interventional pilot study from ProgenaBiome exploring how gut microbiota may influence anxiety has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Depression
A non-interventional pilot study investigating the role of gut microbiota in depression has been withdrawn from the clinical trial registry.
-
CLINICAL_TRIALS withdrawal · 2025-02-06Clinical Trial Update: Clinical Investigation of Syndi [NA]
The clinical investigation of Syndi, sponsored by Newcastle University, has been withdrawn; the trial targeted depression and anxiety-relate…
-
CLINICAL_TRIALS withdrawal · 2024-12-17Clinical Trial Update: Teaching Caregivers of Hospice Patients to Administer Reiki [NA]
A clinical trial at Ohio State University evaluating Reiki administered by hospice caregivers was withdrawn from the study.
-
CLINICAL_TRIALS withdrawal · 2024-12-04Clinical Trial Update: The Development and Piloting of 'Power Up': a Tool for Young People with Internalising/emotional Disorders to Make Shared Decisions in Child and Adolescent Mental Health Services (CAMHS) [NA]
The development and piloting of 'Power Up', a decision-support tool for young people with internalising/emotional disorders in CAMHS, has be…
-
CLINICAL_TRIALS withdrawal · 2024-12-02Clinical Trial Update: Dance4Healing: Explore the Benefits of Tele-Dance in Individuals with an Implantable Cardioverter-defibrillator (ICD) [NA]
A clinical trial investigating Tele-Dance for individuals with an implantable cardioverter-defibrillator (ICD) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-10-24Clinical Trial Update: TDCS-Augmented Prolonged Exposure Therapy [NA]
The clinical trial evaluating TDCS-augmented prolonged exposure therapy for PTSD has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-09-26Clinical Trial Update: A Pilot Study of Buspirone for the Treatment of Anxiety in Youth with Autism Spectrum Disorders [Phase 2]
A Phase 2 pilot trial of buspirone for anxiety in youth with autism spectrum disorders has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-06-28Clinical Trial Update: Double-blind Trial of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders [Phase 2]
Phase 2 double-blind trial of buspirone for treating anxiety in youth with Autism Spectrum Disorder has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-05-16Clinical Trial Update: Augmentation of Standard Psychotherapy With a Habit Change App [NA]
The trial evaluating augmentation of standard psychotherapy with a habit-change app has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-05-16Clinical Trial Update: Improving Mental Health in Diabetes: A Guided Self-Help Study [NA]
A University of Edinburgh clinical trial investigating guided self-help for mental health in people with Type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-05-13Clinical Trial Update: Evaluation of Parturients With Anxiety [NA]
A clinical trial evaluating anxiety in pregnant individuals has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-05-07Clinical Trial Update: Targeted Group-based Psychotherapy to Address Emotional Stress in at Risk ICU Survivors [NA]
A clinical trial studying targeted group-based psychotherapy for emotional stress in at-risk ICU survivors has been withdrawn.
-
EMA withdrawal · 2023-10-12EMA Withdrawn: Pregabalin Sandoz GmbH (pregabalin) — Sandoz GmbH
The EMA withdrew the Pregabalin Sandoz GmbH (pregabalin) product from the market, affecting indications in Anxiety Disorders and Epilepsy.
-
EMA withdrawal · 2023-03-20EMA Withdrawn: Pregabalin Zentiva k.s. (pregabalin) — Zentiva k.s.
The EMA withdrew pregabalin Zentiva k.s. from the market (Zentiva k.s.) with the therapeutic areas including anxiety disorders, neuralgia, a…
-
EMA withdrawal · 2022-04-26EMA Withdrawn: Pregabalin Mylan Pharma (pregabalin) — Mylan S.A.S.
EMA withdrawal notice for pregabalin marketed by Mylan S.A.S., affecting anxiety disorders, neuralgia, and epilepsy indications.
-
EMA withdrawal · 2021-06-22EMA Withdrawn: Nodetrip (previously Xeristar) (duloxetine) — Esteve Pharmaceuticals, S.A.
The EMA has withdrawn Nodetrip (duloxetine) from Esteve Pharmaceuticals, covering indications in anxiety disorders, major depressive disorde…
-
CLINICAL_TRIALS withdrawal · 2019-01-31Clinical Trial Update: "The Evaluation of Stimulant Withdrawal" [Phase 2]
Phase 2 clinical trial evaluating stimulant withdrawal was withdrawn; conditions include anxiety and relapse.
-
CLINICAL_TRIALS withdrawal · 2018-04-09Clinical Trial Update: FamilyLive Feasibility and Effectiveness Study [EARLY_Phase 1]
The FamilyLive feasibility and effectiveness study in mood lability and PTSD/Anxiety has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-03-29Clinical Trial Update: Escitalopram in Anxiety Associated Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [Phase 3]
A Phase 3 trial evaluating escitalopram for anxiety in COPD exacerbations has been withdrawn. No results were reported.